Ursula Ney
Directeur/Membre du Conseil chez PROTEOME SCIENCES PLC
Profil
Ursula M.
Ney is currently a Non-Executive Director at Proteome Sciences Plc and an Independent Non-Executive Director at Scancell Holdings Plc.
She is also a Member of the Governors Board at the University of Plymouth and University of Plymouth Enterprise Ltd.
In the past, she has worked as a CEO, Executive Director & Media Relations Contact at Calliditas Therapeutics Suisse SA, Chief Executive Officer at Charterhouse Therapeutics Ltd., and Director at Affibody AB, Celltech Americas, Inc., and Celltech Group Ltd.
She has also served as a Non-Executive Director at Discuva Ltd.
and as a Principal at Sandoz AG and Roche Diagnostics Ltd.
Dr. Ney holds an MBA from Middlesex University Business School and doctorates from UCL Medical School and Royal Free Hospital Medical School.
Postes actifs de Ursula Ney
| Sociétés | Poste | Début |
|---|---|---|
| PROTEOME SCIENCES PLC | Directeur/Membre du Conseil | 01/08/2017 |
| SCANCELL HOLDINGS PLC | Directeur/Membre du Conseil | 23/10/2019 |
| University of Plymouth | Directeur/Membre du Conseil | - |
University of Plymouth Enterprise Ltd.
 University of Plymouth Enterprise Ltd. Miscellaneous Commercial ServicesCommercial Services Part of University of Plymouth, University of Plymouth Enterprise Ltd. engages in exploitation of assets and intellectual property. The company is based in Plymouth, UK. It was founded in 1999. | Directeur/Membre du Conseil | - |
Anciens postes connus de Ursula Ney
| Sociétés | Poste | Fin |
|---|---|---|
Discuva Ltd.
 Discuva Ltd. Pharmaceuticals: MajorHealth Technology Discuva Ltd. develops antibiotics and drug-resistant pathogens. It is a drug discovery company focused on the creation of microbial against new emerging and drug-resistant bacterial pathogens. The company is headquartered in Cambridge, the United Kingdom. | Directeur/Membre du Conseil | 23/12/2017 |
Sarossa Capital Ltd.
 Sarossa Capital Ltd. Financial ConglomeratesFinance Sarossa Capital Ltd. is an investment holding and management company. Its principal activity is investing in and growth and development of businesses which present opportunities for value creations. The company currently intends to indentify investment opportunities offering the potential to deliver a favorable return to shareholders over the medium term, primarily in the form of capital gain. The company was founded in 1988 and is headquartered in London, the United Kingdom. | Directeur des opérations | 31/03/2010 |
Roche Diagnostics Ltd.
 Roche Diagnostics Ltd. Medical SpecialtiesHealth Technology Roche Diagnostics Ltd. manufactures equipment and reagents for research and medical diagnostic applications. The company was founded on September 14, 1956 and is headquartered in Burgess Hill, the United Kingdom. | Corporate Officer/Principal | - |
Sandoz AG
 Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The company is based in Basel, Switzerland. | Corporate Officer/Principal | - |
Celltech Group Ltd.
 Celltech Group Ltd. Financial ConglomeratesFinance Part of UCB SA, Celltech Group Ltd. is an investment holding British company. The company is based in Slough, UK. Celltech Group was founded in 1987. | Directeur/Membre du Conseil | - |
Formation de Ursula Ney
| UCL Medical School | Doctorate Degree |
| Middlesex University Business School | Masters Business Admin |
| Royal Free Hospital Medical School | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PROTEOME SCIENCES PLC | Health Technology |
| SCANCELL HOLDINGS PLC | Health Technology |
| Entreprise privées | 10 |
|---|---|
Affibody AB
 Affibody AB Miscellaneous Commercial ServicesCommercial Services Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden. | Commercial Services |
Sarossa Capital Ltd.
Sarossa Capital Ltd. Financial ConglomeratesFinance Sarossa Capital Ltd. is an investment holding and management company. Its principal activity is investing in and growth and development of businesses which present opportunities for value creations. The company currently intends to indentify investment opportunities offering the potential to deliver a favorable return to shareholders over the medium term, primarily in the form of capital gain. The company was founded in 1988 and is headquartered in London, the United Kingdom. | Finance |
| Celltech Americas, Inc. | |
| Charterhouse Therapeutics Ltd. | |
Calliditas Therapeutics Suisse SA
 Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland. | Health Technology |
Celltech Group Ltd.
Celltech Group Ltd. Financial ConglomeratesFinance Part of UCB SA, Celltech Group Ltd. is an investment holding British company. The company is based in Slough, UK. Celltech Group was founded in 1987. | Finance |
Sandoz AG
Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The company is based in Basel, Switzerland. | Health Technology |
Roche Diagnostics Ltd.
Roche Diagnostics Ltd. Medical SpecialtiesHealth Technology Roche Diagnostics Ltd. manufactures equipment and reagents for research and medical diagnostic applications. The company was founded on September 14, 1956 and is headquartered in Burgess Hill, the United Kingdom. | Health Technology |
Discuva Ltd.
Discuva Ltd. Pharmaceuticals: MajorHealth Technology Discuva Ltd. develops antibiotics and drug-resistant pathogens. It is a drug discovery company focused on the creation of microbial against new emerging and drug-resistant bacterial pathogens. The company is headquartered in Cambridge, the United Kingdom. | Health Technology |
University of Plymouth Enterprise Ltd.
University of Plymouth Enterprise Ltd. Miscellaneous Commercial ServicesCommercial Services Part of University of Plymouth, University of Plymouth Enterprise Ltd. engages in exploitation of assets and intellectual property. The company is based in Plymouth, UK. It was founded in 1999. | Commercial Services |
